Profiel
Jennifer Zibuda is former Head-Corporate Communications at Alkermes Plc, former Director-Investor Relations & Communications at Prothena Corp.
Plc and former Investor Relations Contact at Portola Pharmaceuticals, Inc.
Eerdere bekende functies van Jennifer Zibuda
Bedrijven | Functie | Einde |
---|---|---|
PROTHENA CORPORATION PLC | Investor Relations Contact | 01-01-2023 |
ALKERMES PLC | Public Communications Contact | 01-06-2018 |
PORTOLA PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
PROTHENA CORPORATION PLC | Health Technology |
ALKERMES PLC | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Portola Pharmaceuticals LLC
Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |